1-9 of 9
Marta Petullà
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Potentially Cured Follicular Lymphoma (PC-FL). an Analysis of 56 Cases with Prognostic Factors Evaluation

Samantha Ferrari, MD, Alessandra Tucci, Gloria Valimberti, MD, Antonella Anastasia, MD, Chiara Bottelli, MD, Marta Petullà, Marina Motta, MD, Angela Passi, MD, Giuseppe Rossi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5328.
https://doi.org/10.1182/blood-2018-99-114896
Published: 2018
Journal Articles

Efficacy and Safety of Decitabine As First-Line Therapy for Elderly Patients with Acute Myeloid Leukemia.a Real Life Multicentric Experience of the Northern Italy

Erika Borlenghi, Carla Filì, MD, Claudia Basilico, MD, Massimo Bernardi, MD, Manuela Caizzi, MD, Rosanna Ciancia, MD, Eros Di Bona, MD, Anna Ermacora, Davide Facchinelli, MD, Nicola Fracchiolla, Monica Fumagalli, Michele Gottardi, MD, Silvia Imbergamo, MD, Daniela Lambertenghi, Alfredo Molteni, MD, Marta Petullà, Marta Riva, MD, Elisabetta Todisco, MD, Giuseppe Rossi, MD, Anna Candoni, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1315.
https://doi.org/10.1182/blood.V130.Suppl_1.1315.1315
Published: 2017
Journal Articles

A Prospective, Non-Randomized, Multicenter, Phase II Study to Assess Safety and Efficacy of the Infusion of Peripheral Blood Stem Cells Obtained from HLA-Haploidentical Familial Donors (mHaploSCI) after Standard Chemotherapy in Elderly Patients with Acute Myeloid Leukemia at Intermediate or Adverse Risk

Mirko Farina, MD, Massimo Bernardi, MD, Valentina Mancini, MD, Arnalda Lanfranchi, Alessandra Beghin, Enrico Morello, MD, Marta Petullà, Erika Borlenghi, Chiara Cattaneo, MD, Roberto Cairoli, MD, Giuseppe Rossi, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4464.
https://doi.org/10.1182/blood.V130.Suppl_1.4464.4464
Published: 2017
Journal Articles

Postremission Therapy with Repeated Courses of HD-Arac, Idarubicin and Limited Autologous Stem Cell Support Achieves a Very Good Long-Term Outcome in ELN Favourable and Intermediate-Risk AML Except in NPM-Mutated Patients Where Relapse May Occur Even after Five Years

Erika Borlenghi, MD, Mirko Farina, MD, Angela Passi, MD, Chiara Pagani, MD, Elisa Cerqui, MD, Chiara Cattaneo, MD, Vincenza Orlando, PharmD, Marta Petullà, PharmD, Angelo Belotti, MD, Giuseppina Ruggeri, Giuseppe Rossi, MD
Journal: Blood
Blood (2016) 128 (22): 3993.
https://doi.org/10.1182/blood.V128.22.3993.3993
Published: 2016
Journal Articles

Outcome of Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) and/or 17p Deletion/ TP 53 Mutations Treated with Ibrutinib According to a Named Patient Program (NPP) in Italy: Preliminary Analysis of a Real Life Retrospective Study

Francesca Romana Mauro, MD PhD, Alessandra Tedeschi, Alfonso Piciocchi, BS, Marina Motta, MD, Emilia Iannella, MD, Lucia Farina, MD PhD, Lydia Scarfo, Roberto Marasca, MD, Marta Coscia, MD PhD, Agostino Cortelezzi, MD, Luca Laurenti, Angela Melpignano, MD, Pier Luigi Zinzani, MD PhD, Stefano Molica, MD, Francesca Re, MD, Alessandro Andriani, MD, Donatella Iolanda Vincelli, MD, Carlo Visco, MD, Alessandro Gozzetti, MD, Ester Maria Orlandi, MD, Livio Trentin, MD, Monica Tani, Catello Califano, MD, Giuseppe Tagariello, MD, Paolo Ghia, MD PhD, Maria Denise Caputo, MD, Adriano Salaroli, MD, Idanna Innocenti, MD, Anna Frustaci, MD, Candida Vitale, MD, Marta Petullà, PharmD, Paolo de Fabritiis, MD, Marco Vignetti, MD, Paola Fazi, MD, Robin Foà
Journal: Blood
Blood (2016) 128 (22): 2038.
https://doi.org/10.1182/blood.V128.22.2038.2038
Published: 2016
Journal Articles

Immunological Derangement in Follicular Lymphoma Patients Developing Severe Side Effects during Treatment with PI3K Inhibitors

Marina Motta, MD, Marco Chiarini, MSC, Marta Petullà, PharmD, Claudia Ghidini, BSC, Marion Vaglio Tessitore, BSC, Viviana Giustini, MSC, Chiara Pagani, MD, Antonella Anastasia, MD, Samantha Ferrari, MD, Alessandra Tucci, Luisa Imberti, MD, Giuseppe Rossi, MD
Journal: Blood
Blood (2015) 126 (23): 1531.
https://doi.org/10.1182/blood.V126.23.1531.1531
Published: 2015
Journal Articles

Validating the Patient's "Fitness" Criteria Proposed to Guide Treatment Decision in Elderly AML: a Multicenter Study on a Population-Based Series of 362 Patients By the Network "Rete Ematologica Lombarda" (REL)

Erika Borlenghi, MD, Chiara Pagani, MD, Claudia Basilico, MD, Massimo Bernardi, MD, Nicola Fracchiolla, MD, Francesca Guidotti, MD, Laura Marbello, MD, Andrea Ferrario, MD, Carlo Messina, MD, Emanuele Ravano, MD, Cinzia Lamorgese, Marta Petullà, Giuseppe Rossi, MD
Journal: Blood
Blood (2014) 124 (21): 279.
https://doi.org/10.1182/blood.V124.21.279.279
Published: 2014
Journal Articles

90Yttrium-Ibritumomab Tiuxetan for Non-Hodgkin Lymphoma: Results after a Median Follow-up of 5 Years in a Single Institution

Antonella Anastasia, Enrico Morello, MD, Alessandra Tucci, MD, Alessandro Re, MD, Marina Motta, MD, Chiara Pagani, MD, Raffaele Giubbini, Giancarlo Magri, Marta Petullà, Giuseppe Rossi, MD
Journal: Blood
Blood (2014) 124 (21): 4455.
https://doi.org/10.1182/blood.V124.21.4455.4455
Published: 2014
Journal Articles

Impact Of Posaconazole Prophylaxis On Invasive Fungal Infection During Acute Myeloid Leukemia Induction Therapy: Correlation With Posaconazole Serum Levels

Chiara Cattaneo, MD, Erika Borlenghi, MD, Annafranca Panzali, Francesca Antoniazzi, MD, Marta Petullà, Francesca Schieppati, MD, Elisa Cerqui, MD, Chiara Pagani, MD, Alessandro Re, MD, Giuseppe Rossi
Journal: Blood
Blood (2013) 122 (21): 3484.
https://doi.org/10.1182/blood.V122.21.3484.3484
Published: 2013